Although there was no significant difference between the two groups of high or low TBCB expression level in AML patients from other two GEO datasets (GSE12417 and GSE71014), there was a trend that TBCB high expression maybe indictive of poor prognosis of AML (Figure S1K-L). This evidence concerns the gene TBCB and acute myeloid leukemia.